Concepedia

Wenyi Lu

WL

Statistics

Publications

24

Citations

1K

H-Index

17

Active since

2013

Affiliations

Tianjin First Center Hospital(Current)

Tianjin Medical University

Nankai University

Chinese Academy of Medical Sciences & Peking Union Medical College

XinHua Hospital

Wenyi Lu is an author at Tianjin First Center Hospital specializing in medicine, hematology, and immunology.

Publications per year

2013–2023

24

Publications

24

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma

Yaqing Cao, Wenyi Lu, Rui Sun et al. · Frontiers in Oncology · 2019 · 155 citations · Full text

Life Sciences, Immunology, Oncology +17

ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

Xiao Chai, Deguan Li, Xiaoli Cao et al. · Scientific Reports · 2015 · 144 citations · Full text

Medicine, Hematology, Pathobiology +17

Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells<i>in vitro</i>and suppresses hematopoiesis in iron overload patients

Wenyi Lu, Mingfeng Zhao, Sajin Rajbhandary et al. · European Journal Of Haematology · 2013 · 87 citations · Full text

Medicine, Hematology, Pathobiology +17

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice

Xin Jin, Xiaoyuan He, Xiaoli Cao et al. · Haematologica · 2018 · 72 citations · Full text

Medicine, Hematology, Pathobiology +15

Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome

Yunxiong Wei, Xia Xiong, Xin Li et al. · Cancer Science · 2021 · 71 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

1–5 of 24